$27.66
0.07% yesterday
Nasdaq, Sep 10, 10:00 pm CET

STAAR Surgical Company Stock price

$27.66
+0.36 1.32% 1M
+8.01 40.76% 6M
+3.37 13.87% YTD
-2.48 8.23% 1Y
-67.39 70.90% 3Y
-24.11 46.57% 5Y
+19.64 244.89% 10Y
+22.21 407.52% 20Y
Nasdaq, Closing price Wed, Sep 10 2025
-0.02 0.07%

Key metrics

Basic
Market capitalization
$1.4b
Enterprise Value
$1.2b
Net debt
positive
Cash
$189.9m
Shares outstanding
49.3m
Valuation (TTM | estimate)
P/E
negative | negative
P/S
6.1 | 5.2
EV/Sales
5.3 | 4.5
EV/FCF
negative
P/B
4.1
Financial Health
Equity Ratio
78.0%
Return on Equity
-5.1%
ROCE
-21.6%
ROIC
-37.0%
Debt/Equity
0.0
Financials (TTM | estimate)
Revenue
$224.5m | $263.0m
EBITDA
$-73.2m | $-30.1m
EBIT
$-81.7m | $-79.7m
Net Income
$-95.3m | $-77.2m
Free Cash Flow
$-43.7m
Growth (TTM | estimate)
Revenue
-32.6% | -16.2%
EBITDA
-331.5% | -350.3%
EBIT
-410.3% | -629.4%
Net Income
-673.2% | -282.1%
Free Cash Flow
-422.6%
Margin (TTM | estimate)
Gross
71.7%
EBITDA
-32.6% | -11.5%
EBIT
-36.4%
Net
-42.5% | -29.4%
Free Cash Flow
-19.5%
More
EPS
$-1.9
FCF per Share
$-0.9
Short interest
17.3%
Employees
1k
Rev per Employee
$270.0k
Show more

Is STAAR Surgical Company a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?

As a Free StocksGuide user, you can view scores for all 7,008 stocks worldwide.

STAAR Surgical Company Stock Analysis

Unlock Scores for Free

Analyst Opinions

17 Analysts have issued a STAAR Surgical Company forecast:

6x Buy
35%
11x Hold
65%

Analyst Opinions

17 Analysts have issued a STAAR Surgical Company forecast:

Buy
35%
Hold
65%

Financial data from STAAR Surgical Company

Income Statement P&L | Balance Sheet | Cash Flow


Quarter TTM Annually
Jun '25
+/-
%
224 224
33% 33%
100%
- Direct Costs 64 64
8% 8%
28%
161 161
39% 39%
72%
- Selling and Administrative Expenses 192 192
2% 2%
86%
- Research and Development Expense 50 50
1% 1%
22%
-73 -73
331% 331%
-33%
- Depreciation and Amortization 8.44 8.44
59% 59%
4%
EBIT (Operating Income) EBIT -82 -82
410% 410%
-36%
Net Profit -95 -95
673% 673%
-42%

In millions USD.

Don't miss a Thing! We will send you all news about STAAR Surgical Company directly to your mailbox free of charge.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

STAAR Surgical Company Stock News

Neutral
GlobeNewsWire
about 2 hours ago
NEW YORK, Sept. 11, 2025 (GLOBE NEWSWIRE) -- Halper Sadeh LLC, an investor rights law firm, is investigating whether the sale of STAAR Surgical Company (NASDAQ: STAA) to Alcon for $28.00 per share in cash is fair to STAAR shareholders.
Neutral
GlobeNewsWire
2 days ago
SAN DIEGO, Sept. 09, 2025 (GLOBE NEWSWIRE) -- Shareholder rights law firm Johnson Fistel, PLLP continues its investigation into whether the board members of STAAR Surgical Company (NASDAQ: STAA) breached their fiduciary duties in connection with the proposed sale of the Company to Alcon (NYSE: ALC).
Neutral
Business Wire
9 days ago
LAKE FOREST, Calif.--(BUSINESS WIRE)--STAAR Surgical Company (NASDAQ: STAA), the global leader in phakic IOLs with the EVO family of Implantable Collamer® Lenses (EVO ICL™) for vision correction, issued the following statement: “The merger with Alcon provides STAAR stockholders with compelling, premium cash value, including a 51% premium to the closing price of STAAR common stock on August 4, 2...
More STAAR Surgical Company News

Company Profile

STAAR Surgical Co. engages in the development, manufacture, production, marketing, and sale of implantable lenses for the eye and delivery systems used to deliver the lenses into the eye. It specializes in refractive and cataract solutions. Its products include intraocular lens and implantable collamer lens. The company was founded in 1982 and is headquartered in Lake Forest, CA.

Head office United States
CEO Stephen Farrell
Employees 1,157
Founded 1982
Website www.staar.com

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today